| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| Syndecan-1 | HOT SY1-H5253 | Human Syndecan-1 Protein, Fc Tag | Human | HEK293 | ![]() | SDS-PAGE | $360.00 100ug | ||
| Syndecan-1 | HOTAvitag SY1-H82F3 | Biotinylated Human Syndecan-1 Protein, Fc,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | ||
| Syndecan-1 | HOT SY1-H5225 | Human Syndecan-1 Protein, His Tag | Human | HEK293 | ![]() | SDS-PAGE | $360.00 100ug | ||
| Syndecan-1 | HOTAvitag SY1-H82E2 | Biotinylated Human Syndecan-1 Protein, His,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | ||
| Syndecan-1 | FITC-Labeled Human Syndecan-1 Protein, His Tag | Human | HEK293 | ![]() | SDS-PAGE | $330.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| ATLCAR.CD138 (UNC Lineberger Comprehensive Cancer Center) | Phase 1 Clinical | Unc Lineberger Comprehensive Cancer Center | Immune System Diseases; Multiple Myeloma | Details | |
| QXL-138AM | QXL-138AM | Phase 1 Clinical | Nammi Therapeutics Inc | Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Gastrointestinal Neoplasms; Lung Neoplasms; Multiple Myeloma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours | Details |